Cookie Consent by

June 3, 2021

HUTER posters accepted in the forthcoming HUMAN CELL ATLAS Virtual Meeting

Two posters will be presented by the HUTER consortia at the HUMAN CELL ATLAS Virtual Meeting that will be held on June 28th -30th 2021.

The presentations have been scheduled within Session #1, June 29, 13:30-15:00 CET.

Event: Abstracts presentation HCA General Meeting

Date: June 28th -30th 2021 (Session #1, June 29, 13:30-15:00 CET)

The goals of the 2021 HCA General Meeting are to convene the HCA community virtually and to share updates and insights on new HCA research and initiatives, as well as to highlight the work of the HCA Biological Networks and continue to build on the progress from the HCA Biological Network Seminar Series.

The HCA will count with a virtual poster room, with two interactive poster viewing sessions: One session in a time zone convenient to Asia/Australia and the other in a time zone convenient to Africa/Americas/Europe.

HUTER is represented in the Reproduction Biological Network through the network coordinators Dr. Cecilia Lindskog and Dr. Roser Vento-Tormo.

The two abstracts accepted will be presented by Bahía Software, partner developing the platform and INCLIVA.

About the Human Uterus Cells Atlas – HUTER

The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women´s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine.

The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women ́s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity.

HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.

Link to the project website here